Related Experiment Videos
Medium chain acyl-coenzyme A dehydrogenase deficiency and SIDS
T Hegyi1, B Ostfeld, K Gardner
1Division of Neonatology, St. Peter's Medical Center, UMDNJ-Robert Wood Johnson Medical School, New Brunswick 08903.
New Jersey Medicine : the Journal of the Medical Society of New Jersey
|May 1, 1992
Summary
Medium chain acyl-coenzyme A dehydrogenase deficiency (MCADD) is a serious genetic disorder affecting fatty acid metabolism. Early diagnosis and intervention are crucial for preventing sudden infant death syndrome (SIDS) and managing this condition.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Medium chain acyl-coenzyme A dehydrogenase deficiency (MCADD) is an inherited metabolic disorder.
- It impairs the body's ability to break down fats for energy.
- MCADD is a potential, often undiagnosed, cause of sudden infant death syndrome (SIDS).
Purpose of the Study:
- To highlight MCADD as a significant factor in SIDS.
- To emphasize the availability of effective diagnostic and therapeutic strategies for MCADD.
Main Methods:
- Review of existing literature on MCADD and SIDS.
- Analysis of metabolic pathways involved in fatty acid oxidation.
- Case study reviews linking MCADD to unexplained infant deaths.
Main Results:
- MCADD is a treatable condition with available therapies.
- Failure to diagnose MCADD can lead to fatal outcomes, mimicking SIDS.
- Genetic screening and metabolic testing are key for identification.
Conclusions:
- MCADD represents a preventable cause of infant mortality.
- Awareness and timely diagnosis of MCADD are critical for infant health.
- Effective management strategies exist for individuals with MCADD.